is retatrutide a glp-1 drug RETATRUTIDE: Medication for Diabetes and Weight Loss Retatrutide vs. Tirzepatide: The Next-Gen

But the data suggest that this success is conditional

Over the past decade, four landmark cardiovascular outcome trials have quietly rewritten how we think about cardiometabolic risk: LEADER (2016) Liraglutide cut MACE by 13%, CV death by 22%, and all-cause mortality by 15% in high-risk T2DM patients

In some patients, constipation may not be caused by slow digestion alone

As more nuanced measures gain acceptance, the rigid BMI cutoffs may evolve into more flexible, multi-factor assessments

Food tolerability returns to near-normal levels

Digestion Changes: By slowing down digestion, GLP-1 RAs may affect how well your body absorbs some vitamins and minerals